vs 7,393 other HR bills in the 115th — cohort avg 50d
Summary
Lymphedema Treatment Act This bill amends title XVIII (Medicare) of the Social Security Act to cover certain lymphedema compression treatment items as durable medical equipment under Medicare. (Lymphedema is a condition of localized fluid retention and tissue swelling that is caused when the lymphatic system is damaged or blocked.)
Lobbying filings that explicitly cite this bill (50)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Client expense: $650,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
Physician self-referra/Stark Law
American Cures Act
H.R. 930/S.497 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
Medicaid Expansion
HR. 1639/S.619 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 302/S.808 Sports Medicine Licensure Clarity Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 1361/S.486 Ensuring Access to Quality CRT
Medicare Telehealth Parity Act HR2550
American Healthcare Act of 2017/CONNECT - H.R. 2556/S1016
H.R. 1628 - American Health Care Action of 2017
Opioid Epidemic/Pain Management
Better Care Reconciliation Act of 2017
H.R.2066 Promoting Integrity in Medicare
H.R. 2063 Opioid Pace Act of 2017
H.R. 5261 Teach Act
H.R. 5197 Alto Act
H.R. 5686, Medicare Clear Health Options in Care for Enrollees Act
H.R. 5773, Preventing Addiction for Susceptible Seniors Act
H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act
H.R. 5718, Perioperative Reduction for Opioids Act
H.R. 5719, Reduce Overprescribing Opioids in Treatment Act
H.R. 5722, Dr. Todd Graham Pain Management Improvement Act
H.R. 6, Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act
S. 3120, the HEAL Act
S. 2680, Opioid Crisis Response Act
Association Retirement Plans
State Relief and Empowerment Waivers
D.O.L Information Collection Request Extensions
Health Reimbursement Accounts
HR 7217: Improve Act
Client expense: $252,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment;
H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care;
H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography;
H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue;
S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
H.R.1017, Removing Barriers to Colorectal Cancer Screening Act.
Clinical trial policy.
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, all provisions
H.R. 930, Lymphedema Treatment Act, all provisions
S. 497, Lymphedema Treatment Act, all provisions
H.R. 6836, CLINICAL TREATMENT Act, all provisions
S. 3592, No More Surprise Medical Bills Act of 2018, all provisions
H.R. 7122, Shared Accountability for Improved Patient Outcomes Act of 2018, all provisions
H.R. 6, SUPPORT for Patients and Communities Act, all provisions
S. 3120, HEAL Act of 2018, all provisions
H.R.3528 - Every Prescription Conveyed Securely Act, all provisions
S. 2460, Every Prescription Conveyed Securely Act, all provisions
H.R. 2687, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions
S. 1169, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions
S. 1016, CONNECT for Health Act of 2017, provisions relating to telehealth
Medicare program: Protecting Patients from Surprise Medical Bills Act
Medicare program: Protecting Access to Medicare Act (PAMA)/physician office labs
Medicare program: Medicare Access and Chip Reauthorization Act (MACRA) implementation
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: MIPS cost measures
Medicare program: MIPS impact on Part B drugs and DME
Medicare program: Physician-Focused Payment Model Technical Advisory Committee (PTAC)
Medicare program: Diabetes Prevention Program/virtual coverage
Medicare program: Evaluation and Management Codes/documentation
Medicare program: Medicare physician fee schedule
Medicare program: Medicare Advantage (MA) and Part D
Medicare program: Quality Payment Program
Medicare program: Shared Savings Program
Medicare program: Health IT burdens
Medicare program: Surprise billing
Medicare program: Graduate Medical Education (GME)
Medicare program: Alternative Payment Models (APMs)
Medicare program: Appropriate Use Criteria
Medicare program: Cybersecurity
Medicare program: Interoperability
Medicare program: Stark/Anti-kickback
Medicare program: Privacy
Medicare program: Regulatory relief
Medicare program: Step therapy
Medicare program: Residents/minor procedures
Medicare program: Prior authorization and utilization management
Medicare program: Medicare for all
Medicare program: Open Payments
Medicare program: PECOS/Medicare Enrollment/Revocations/Revalidations
Medicare program: Pharmacy Benefit Manager (PBM)/drug price transparency
Medicare program: Misvalued codes
Medicare program: List price for drugs
Medicare program: Drug pricing transparency
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $4,740,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Bureau of Citizenship & Immigration Services (BCIS), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Natl Drug Control Policy (NDCP), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; H.R. 4122 & S. 2006, the Breast Density & Mammography Reporting Act; and H.R.820 & S.292, the Childhood Cancer STAR Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. The proposed Medical Records Fairness Act (no number yet). Issues regarding the Affordable Care Act premium tax credits and catastrophic plans, HR 6311. Issues regarding protections for people with pre-existing conditions, including S. 3388, HR 6898, and H. Res. 1066. Resolutions to disapprove the short-term rule, H.J. Res 140 and S. J. Res. 63. Advocacy against including the Association Health Plan provision of the House Farm bill in the conference report, H.R. 2 and s. 3042 (section 6004 of the House-passed version of the legislation). Issues involving patient navigation, including the Patient Navigation Assistance Act, HR 6808. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018. H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018. Issues related to caregiving, including H.R. 3759/S. 1028, the RAISE Family Caregivers Act, H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for.
Client expense: $1,610,710 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Medicare and Medicaid payment quality programs and policies, including: healthcare associated complications, infections, readmission, payment bundling, potentially preventable events and outcomes, transparency and value based purchasing
Medicare and Medicaid data, Medicaid Scorecards, health information exchanges (HIEs), interoperability, and patient-centered medical records policies
Opioid epidemic related policies
Implementation of the Patient Protection and Affordable Care Act (PL 111-148)
Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (Public Law No: 114-255)
Implementation of the Medicare Access CHIP Reauthorization Act (MACRA)(PL 114-10)
Implementation of The Health Information Technology for Economic an Clinical Health Act (HITECH Act - part of the American Recovery and Reinvestment Act of 2009, PL 111-5)
Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10)
S.428, ACE Kids Act
H.R. 3325, ACE Kids Act
H.R.3611, The Healthcare Outcomes Act
H.R.3922 Championing Healthy Kids Act
S.1827, Kids' Insurance Dependable and Secure (KIDS)
S.497 Lymphedema Treatment Act
H.R. 930 Lymphedema Treatment Act
Client expense: $670,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
H.R.184 Protect Medical Innovation Act of 2018
S.108 Medical Device Access and Innovation Protection Act
Medicare and Medicaid payment quality programs and policies, including: healthcare associated complications, infections, readmission, payment bundling, potentially preventable events and outcomes, transparency, and value based purchasing
Medicare and Medicaid data, Medicaid Scorecards, health information exchanges (HIEs), interoperability, and patient-centered medical records policies
Opioid epidemic related policies
Implementation of the Patient Protection and Affordable Care Act (PL 111-148)
Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (Public Law No: 114-255)
Implementation of the Medicare Access CHIP Reauthorization Act (MACRA)(PL 114-10)
Implementation of The Health Information Technology for Economic and Clinical Health Act (HITECH Act - part of the American Recovery and Reinvestment Act of 2009, PL 111-5)
Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10)
S.428, ACE Kids Act
H.R. 3325, ACE Kids Act
H.R.3611 The Healthcare Outcomes Act
H.R.3922 Championing Healthy Kids Act
S.1827 Kids' Insurance Dependable and Secure (KIDS)
S.497 Lymphedema Treatment Act
H.R. 930 Lymphedema Treatment Act
Client expense: $670,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA)
PL 114-10 - Medicare and CHIP Reauthorization Act of 2017 Implementation
H.R. 6 - SUPPORT for Patients and Communities Act
H.R. 5507 - Critical Access Hospital Relief Act of 2018
H. R. 5809 - Postoperative Opioid Prevention Act of 2018
H.R 4143/S. 2065 - Dialysis PATIENTS Demonstration Act of 2017
S. 2852/H.R. 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI)
H.R. 5385 - Children's Hospital GME Support Reauthorization Act of 2018
S. 2809 - A bill to amend title XVIII of the Social Security Act to provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
H.R. 5106 - Investor Choice Against Gun Proliferation Act
H.R.1057 - STOP Act of 2017
H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017
H.R. 880/S. 1022 - Mission Zero Act
H.R. 1017/S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017
H.R. 820/S. 292 - Childhood Cancer STAR Act
H.R. 5160 - Cancer Care Planning and Communications Act of 2018
H.R. 1704 - ACCESS Act of 2017
H.R. 2267 - Resident Physician Shortage Reduction Act of 2017
H.R. 1676/S. 693 - Palliative Care and Hospice Education and Training Act
H.R. 4909/S. 2495 - STOP School Violence Act of 2018
H.R. 4841 - Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act
H.R. 1892 - Bipartisan Budget Act of 2018
H.R. 1625 - Omnibus
H.R. 2906/S. 1351 - Ensuring Access to General Surgery Act of 2017
H.R. 4434/S.2135 - Fix NICS Act of 2017
H.R. 548/S. 527 - Health Care Safety Net Enhancement Act of 2017
H.R. 849/S. 260, S. 251 - Protecting Seniors' Access to Medicare Act of 2017
H.R. 2843/S.1317 - Medicaid and CHIP Quality Improvement Act of 2017
H.R. 3120 - Electronic Health Record Meaningful Use
H.R. 2276/S.2575 - Audiology Patient Choice Act of 2018
H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
H.R. 6545 - Violence Against Women Reauthorization Act of 2018
H.R. 6808 - Patient Navigation Assistance Act of 2018
H.R.4897 - Women and Lung Cancer Research and Preventive Services Act of 2018
H.R. 930/S. 497 - Lymphedema Treatment Act
H.R. 7083 - Access to Genetic Counselor Services Act of 2018
H.R. 1318 - Preventing Maternal Deaths Act of 2018
Medicaid GME Transparency Act
Bleeding Control for the Injured (Stop The Bleed campaign)
Injury Prevention Initiatives
Childrens Health Insurance Program Reauthorization
Cancer Research and Funding
Opioids
EHR Clinician Burden/Administrative Burden
Mis-valued Codes
Medicare Sequestration
Congenital Anomalies
Global Codes
Qualified clinical data registry (QCDR)
Consumer Assessment of Healthcare Providers and Systems Surgical Care Survey (S-CAHPS)
VA Health Issues
DOD Health Issues
The Emergency Medical Services for Children Program
MIPS cost measure development
E-Prior Authorization
Digital health systems
Sports Medicine
Firearms Research
Hospital-based violence intervention programs
National Trauma System (Military-Civilian Trauma Care)
Visa Denial
Medicare Fraud
Surprise Billing Draft Legislation
Stark Law Reform and Medicare
Administrative Burden relief
Alternative Payment Models (APMs)
Physician Fee Schedule
Quality Payment Program (QPP)
Out-of-Network billing
Narrow networks/Network Adequacy
Hospital-based Violence Intervention Programs
Out of the Crucible: U.S. Military Combat Casualty Care principles
Client expense: $16,092 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA)
PL 114-10 - Medicare and CHIP Reauthorization Act of 2017 Implementation
H.R. 6 - SUPPORT for Patients and Communities Act
H.R. 5507 - Critical Access Hospital Relief Act of 2018
H. R. 5809 - Postoperative Opioid Prevention Act of 2018
H.R 4143/S. 2065 - Dialysis PATIENTS Demonstration Act of 2017
S. 2852/H.R. 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI)
H.R. 5385 - Children's Hospital GME Support Reauthorization Act of 2018
S. 2809 - A bill to amend title XVIII of the Social Security Act to provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
H.R. 5106 - Investor Choice Against Gun Proliferation Act
H.R.1057 - STOP Act of 2017
H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017
H.R. 880/S. 1022 - Mission Zero Act
H.R. 1017/S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017
H.R. 820/S. 292 - Childhood Cancer STAR Act
H.R. 5160 - Cancer Care Planning and Communications Act of 2018
H.R. 1704 - ACCESS Act of 2017
H.R. 2267 - Resident Physician Shortage Reduction Act of 2017
H.R. 1676/S. 693 - Palliative Care and Hospice Education and Training Act
H.R. 4909/S. 2495 - STOP School Violence Act of 2018
H.R. 4841 - Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act
H.R. 1892 - Bipartisan Budget Act of 2018
H.R. 1625 - Omnibus
H.R. 2906/S. 1351 - Ensuring Access to General Surgery Act of 2017
H.R. 4434/S.2135 - Fix NICS Act of 2017
H.R. 548/S. 527 - Health Care Safety Net Enhancement Act of 2017
H.R. 849/S. 260, S. 251 - Protecting Seniors' Access to Medicare Act of 2017
H.R. 2843/S.1317 - Medicaid and CHIP Quality Improvement Act of 2017
H.R. 3120 - Electronic Health Record Meaningful Use
H.R. 2276/S.2575 - Audiology Patient Choice Act of 2018
H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
H.R. 6545 - Violence Against Women Reauthorization Act of 2018
H.R. 6808 - Patient Navigation Assistance Act of 2018
H.R.4897 - Women and Lung Cancer Research and Preventive Services Act of 2018
H.R. 930/S. 497 - Lymphedema Treatment Act
H.R. 7083 - Access to Genetic Counselor Services Act of 2018
H.R. 1318 - Preventing Maternal Deaths Act of 2018
Medicaid GME Transparency Act
Bleeding Control for the Injured (Stop The Bleed campaign)
Injury Prevention Initiatives
Childrens Health Insurance Program Reauthorization
Cancer Research and Funding
Opioids
EHR Clinician Burden/Administrative Burden
Mis-valued Codes
Medicare Sequestration
Congenital Anomalies
Global Codes
Qualified clinical data registry (QCDR)
Consumer Assessment of Healthcare Providers and Systems Surgical Care Survey (S-CAHPS)
VA Health Issues
DOD Health Issues
The Emergency Medical Services for Children Program
MIPS cost measure development
E-Prior Authorization
Digital health systems
Sports Medicine
Firearms Research
Hospital-based violence intervention programs
National Trauma System (Military-Civilian Trauma Care)
Visa Denial
Medicare Fraud
Surprise Billing Draft Legislation
Stark Law Reform and Medicare
Administrative Burden relief
Alternative Payment Models (APMs)
Physician Fee Schedule
Quality Payment Program (QPP)
Out-of-Network billing
Narrow networks/Network Adequacy
Hospital-based Violence Intervention Programs
Out of the Crucible: U.S. Military Combat Casualty Care principles
Client expense: $16,092 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA)
PL 114-10 - Medicare and CHIP Reauthorization Act of 2017 Implementation
H.R. 6 - SUPPORT for Patients and Communities Act
H.R. 5507 - Critical Access Hospital Relief Act of 2018
H. R. 5809 - Postoperative Opioid Prevention Act of 2018
H.R 4143/S. 2065 - Dialysis PATIENTS Demonstration Act of 2017
S. 2852/H.R. 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI)
H.R. 5385 - Children's Hospital GME Support Reauthorization Act of 2018
S. 2809 - A bill to amend title XVIII of the Social Security Act to provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
H.R. 5106 - Investor Choice Against Gun Proliferation Act
H.R.1057 - STOP Act of 2017
H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017
H.R. 880/S. 1022 - Mission Zero Act
H.R. 1017/S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017
H.R. 820/S. 292 - Childhood Cancer STAR Act
H.R. 5160 - Cancer Care Planning and Communications Act of 2018
H.R. 1704 - ACCESS Act of 2017
H.R. 2267 - Resident Physician Shortage Reduction Act of 2017
H.R. 1676/S. 693 - Palliative Care and Hospice Education and Training Act
H.R. 4909/S. 2495 - STOP School Violence Act of 2018
H.R. 4841 - Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act
H.R. 1892 - Bipartisan Budget Act of 2018
H.R. 1625 - Omnibus
H.R. 2906/S. 1351 - Ensuring Access to General Surgery Act of 2017
H.R. 4434/S.2135 - Fix NICS Act of 2017
H.R. 548/S. 527 - Health Care Safety Net Enhancement Act of 2017
H.R. 849/S. 260, S. 251 - Protecting Seniors' Access to Medicare Act of 2017
H.R. 2843/S.1317 - Medicaid and CHIP Quality Improvement Act of 2017
H.R. 3120 - Electronic Health Record Meaningful Use
H.R. 2276/S.2575 - Audiology Patient Choice Act of 2018
H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
H.R. 6545 - Violence Against Women Reauthorization Act of 2018
H.R. 6808 - Patient Navigation Assistance Act of 2018
H.R.4897 - Women and Lung Cancer Research and Preventive Services Act of 2018
H.R. 930/S. 497 - Lymphedema Treatment Act
H.R. 7083 - Access to Genetic Counselor Services Act of 2018
H.R. 1318 - Preventing Maternal Deaths Act of 2018
Medicaid GME Transparency Act
Bleeding Control for the Injured (Stop The Bleed campaign)
Injury Prevention Initiatives
Childrens Health Insurance Program Reauthorization
Cancer Research and Funding
Opioids
EHR Clinician Burden/Administrative Burden
Mis-valued Codes
Medicare Sequestration
Congenital Anomalies
Global Codes
Qualified clinical data registry (QCDR)
Consumer Assessment of Healthcare Providers and Systems Surgical Care Survey (S-CAHPS)
VA Health Issues
DOD Health Issues
The Emergency Medical Services for Children Program
MIPS cost measure development
E-Prior Authorization
Digital health systems
Sports Medicine
Firearms Research
Hospital-based violence intervention programs
National Trauma System (Military-Civilian Trauma Care)
Visa Denial
Medicare Fraud
Surprise Billing Draft Legislation
Stark Law Reform and Medicare
Administrative Burden relief
Alternative Payment Models (APMs)
Physician Fee Schedule
Quality Payment Program (QPP)
Out-of-Network billing
Narrow networks/Network Adequacy
Hospital-based Violence Intervention Programs
Out of the Crucible: U.S. Military Combat Casualty Care principles
Client expense: $169,817 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA)
PL 114-10 - Medicare and CHIP Reauthorization Act of 2017 Implementation
H.R. 6 - SUPPORT for Patients and Communities Act
H.R. 5507 - Critical Access Hospital Relief Act of 2018
H. R. 5809 - Postoperative Opioid Prevention Act of 2018
H.R 4143/S. 2065 - Dialysis PATIENTS Demonstration Act of 2017
S. 2852/H.R. 6378 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI)
H.R. 5385 - Children's Hospital GME Support Reauthorization Act of 2018
S. 2809 - A bill to amend title XVIII of the Social Security Act to provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
H.R. 5106 - Investor Choice Against Gun Proliferation Act
H.R.1057 - STOP Act of 2017
H.R. 1822, 1876/S. 781 - Good Samaritan Health Professionals Act of 2017
H.R. 880/S. 1022 - Mission Zero Act
H.R. 1017/S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017
H.R. 820/S. 292 - Childhood Cancer STAR Act
H.R. 5160 - Cancer Care Planning and Communications Act of 2018
H.R. 1704 - ACCESS Act of 2017
H.R. 2267 - Resident Physician Shortage Reduction Act of 2017
H.R. 1676/S. 693 - Palliative Care and Hospice Education and Training Act
H.R. 4909/S. 2495 - STOP School Violence Act of 2018
H.R. 4841 - Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act
H.R. 1892 - Bipartisan Budget Act of 2018
H.R. 1625 - Omnibus
H.R. 2906/S. 1351 - Ensuring Access to General Surgery Act of 2017
H.R. 4434/S.2135 - Fix NICS Act of 2017
H.R. 548/S. 527 - Health Care Safety Net Enhancement Act of 2017
H.R. 849/S. 260, S. 251 - Protecting Seniors' Access to Medicare Act of 2017
H.R. 2843/S.1317 - Medicaid and CHIP Quality Improvement Act of 2017
H.R. 3120 - Electronic Health Record Meaningful Use
H.R. 2276/S.2575 - Audiology Patient Choice Act of 2018
H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
H.R. 6545 - Violence Against Women Reauthorization Act of 2018
H.R. 6808 - Patient Navigation Assistance Act of 2018
H.R.4897 - Women and Lung Cancer Research and Preventive Services Act of 2018
H.R. 930/S. 497 - Lymphedema Treatment Act
H.R. 7083 - Access to Genetic Counselor Services Act of 2018
H.R. 1318 - Preventing Maternal Deaths Act of 2018
Medicaid GME Transparency Act
Bleeding Control for the Injured (Stop The Bleed campaign)
Injury Prevention Initiatives
Childrens Health Insurance Program Reauthorization
Cancer Research and Funding
Opioids
EHR Clinician Burden/Administrative Burden
Mis-valued Codes
Medicare Sequestration
Congenital Anomalies
Global Codes
Qualified clinical data registry (QCDR)
Consumer Assessment of Healthcare Providers and Systems Surgical Care Survey (S-CAHPS)
VA Health Issues
DOD Health Issues
The Emergency Medical Services for Children Program
MIPS cost measure development
E-Prior Authorization
Digital health systems
Sports Medicine
Firearms Research
Hospital-based violence intervention programs
National Trauma System (Military-Civilian Trauma Care)
Visa Denial
Medicare Fraud
Surprise Billing Draft Legislation
Stark Law Reform and Medicare
Administrative Burden relief
Alternative Payment Models (APMs)
Physician Fee Schedule
Quality Payment Program (QPP)
Out-of-Network billing
Narrow networks/Network Adequacy
Hospital-based Violence Intervention Programs
Out of the Crucible: U.S. Military Combat Casualty Care principles
Client expense: $169,817 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
S. 977/HR 3820 and HR 6225: Medicare Home Health Flexibility Act - Advocate for passage .
HR 2550: Medicare Telehealth Parity Act of 2017 - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
HR2556: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; S787: A bill to require the Center for Medicare and Medicaid Innovation to test the effect of including telehealth services in Medicare health care delivery reform models; HR3360: Telehealth Enhancement Act; HR3482: Evidence-Based Telehealth Expansion Act; S1016: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; and HR3727: A bill to amend title XVIII of the Social Security Act to include additional telehealth services for purposes of MA organization bids, and for other purposes. - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
No bill# Red Tape Reduction Initiative from Ways and Means Committee: Submitted following priorities for occupational therapy red tape reduction - 1) Initiation of Home Health Therapy Services Under Medicare (S. 977/HR 3820 now HR 6225), 2) Recognition of Occupational Therapy as a Primary Rehab Service (no bill number), 3) Permanently Eliminate Outside Certification Requirement for Occupational Therapists to Fabricate Custom Orthotics and Prosthetic Items (no bill number), 4) Modify or Eliminate Claims-Based Data Collection of Functional Limitation Information for Therapy Services (no bill number), 5) Add Doctor-prescribed Compression Supplies to the Durable Medical Equipment category (S 497/HR 930), and 6) Medicare Opt-out Option (no bill number).
No Bill: Discussed how Stark laws affect the ability of occupational therapy practitioners to provide coordinated care services, particularly as it relates to the management of chronic conditions.
S. 497/HR 930: Lymphedema Treatment Act - Support passage.
No bill: Advocate for role of skilled therapy in changing reimbursement under Medicare Part A and Part B.
HR 6 SUPPORT for Patients and Communities Act (PL 115-271) and various bills on opioids HR 5722, HR 5774, HR 5776, HR 6110, S 3008 and S 3120: Educate Members of Congress about the role of occupational therapy in the non-pharmacological management of pain, and advocate for any legislation that includes studies or funding for these alternatives, includes occupational therapy.
Discussed and examined the effect of changes to reimbursement for occupational therapy assistants included in the Bi-partisan Budget Act, and possibly requesting a report from the GAO.
S. 2387/HR 4957 - Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018: Support
Client expense: $210,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
Physician self-referra/Stark Law
American Cures Act
H.R. 930/S.497 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
Medicaid Expansion
HR. 1639/S.619 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 302/S.808 Sports Medicine Licensure Clarity Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 1361/S.486 Ensuring Access to Quality CRT
Medicare Telehealth Parity Act HR2550
American Healthcare Act of 2017/CONNECT - H.R. 2556/S1016
H.R. 1628 - American Health Care Action of 2017
Opioid Epidemic/Pain Management
Better Care Reconciliation Act of 2017
H.R.2066 Promoting Integrity in Medicare
H.R. 2063 Opioid Pace Act of 2017
H.R. 5261 Teach Act
H.R. 5197 Alto Act
H.R. 5686, Medicare Clear Health Options in Care for Enrollees Act
H.R. 5773, Preventing Addiction for Susceptible Seniors Act
H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act
H.R. 5718, Perioperative Reduction for Opioids Act
H.R. 5719, Reduce Overprescribing Opioids in Treatment Act
H.R. 5722, Dr. Todd Graham Pain Management Improvement Act
H.R. 6, Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act
S. 3120, the HEAL Act
S. 2680, Opioid Crisis Response Act
Association Retirement Plans
State Relief and Empowerment Waivers
D.O.L Information Collection Request Extensions
Health Reimbursement Accounts
HR 7217: Improve Act
Client expense: $252,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Promote Medicare coverage of physician prescribed compression garments for lymphedema patients. This includes S. 497 and H.R. 930, the Lymphedema Treatment Act.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment;
H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care;
H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography;
H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue;
S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
H.R.1017, Removing Barriers to Colorectal Cancer Screening Act.
Clinical trial policy.
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; H.R. 4122 & S. 2006, the Breast Density & Mammography Reporting Act; H.R.820 & S.292, the Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, issues related to reform of laboratory and diagnostic tests and the development of a new discussion draft for the Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. The proposed Medical Records Fairness Act (no number yet). Issues regarding the Affordable Care Act premium tax credits and catastrophic plans, HR 6311. Issues regarding protections for people with pre-existing conditions, including S. 3388, HR 6898, and H. Res. 1066. Resolutions to disapprove the short-term rule, H.J. Res 140 and S. J. Res. 63. Advocacy against including the Association Health Plan provision of the House Farm bill in the conference report, H.R. 2 and s. 3042 (section 6004 of the House-passed version of the legislation). Issues involving patient navigation, including the Patient Navigation Assistance Act, HR 6808. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests. H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018. Issues related to caregiving, including H.R. 3759/S. 1028, the RAISE Family Caregivers Act.
Client expense: $1,230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Medicare and Medicaid payment quality programs and policies, including: healthcare associated complications, infections, readmission, payment bundling, potentially preventable events and outcomes, transparency and value based purchasing
Medicare and Medicaid data, Medicaid Scorecards, health information exchanges (HIEs), interoperability, and patient-centered medical records policies
Opioid epidemic related policies
Implementation of the Patient Protection and Affordable Care Act (PL 111-148)
Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (Public Law No: 114-255)
Implementation of the Medicare Access CHIP Reauthorization Act (MACRA)(PL 114-10)
Implementation of The Health Information Technology for Economic an Clinical Health Act (HITECH Act - part of the American Recovery and Reinvestment Act of 2009, PL 111-5)
Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10)
S.428, ACE Kids Act
H.R. 3325, ACE Kids Act
H.R.3611, The Healthcare Outcomes Act
H.R.3922 Championing Healthy Kids Act
S.1827, Kids' Insurance Dependable and Secure (KIDS)
S.497 Lymphedema Treatment Act
H.R. 930 Lymphedema Treatment Act
Client expense: $1,100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
H.R.184 Protect Medical Innovation Act of 2018
S.108 Medical Device Access and Innovation Protection Act
Medicare and Medicaid payment quality programs and policies, including: healthcare associated complications, infections, readmission, payment bundling, potentially preventable events and outcomes, transparency, and value based purchasing
Medicare and Medicaid data, Medicaid Scorecards, health information exchanges (HIEs), interoperability, and patient-centered medical records policies
Opioid epidemic related policies
Implementation of the Patient Protection and Affordable Care Act (PL 111-148)
Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (Public Law No: 114-255)
Implementation of the Medicare Access CHIP Reauthorization Act (MACRA)(PL 114-10)
Implementation of The Health Information Technology for Economic and Clinical Health Act (HITECH Act - part of the American Recovery and Reinvestment Act of 2009, PL 111-5)
Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10)
S.428, ACE Kids Act
H.R. 3325, ACE Kids Act
H.R.3611 The Healthcare Outcomes Act
H.R.3922 Championing Healthy Kids Act
S.1827 Kids' Insurance Dependable and Secure (KIDS)
S.497 Lymphedema Treatment Act
H.R. 930 Lymphedema Treatment Act
Client expense: $1,100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
S. 977/HR 3820 and HR 6225: Medicare Home Health Flexibility Act - Advocate for passage .
HR 2550: Medicare Telehealth Parity Act of 2017 - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
HR2556: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; S787: A bill to require the Center for Medicare and Medicaid Innovation to test the effect of including telehealth services in Medicare health care delivery reform models; HR3360: Telehealth Enhancement Act; HR3482: Evidence-Based Telehealth Expansion Act; S1016: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; and HR3727: A bill to amend title XVIII of the Social Security Act to include additional telehealth services for purposes of MA organization bids, and for other purposes. - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
No bill# Red Tape Reduction Initiative from Ways and Means Committee: Submitted following priorities for occupational therapy red tape reduction - 1) Initiation of Home Health Therapy Services Under Medicare (S. 977/HR 3820 now HR 6225), 2) Recognition of Occupational Therapy as a Primary Rehab Service (no bill number), 3) Permanently Eliminate Outside Certification Requirement for Occupational Therapists to Fabricate Custom Orthotics and Prosthetic Items (no bill number), 4) Modify or Eliminate Claims-Based Data Collection of Functional Limitation Information for Therapy Services (no bill number), 5) Add Doctor-prescribed Compression Supplies to the Durable Medical Equipment category (S 497/HR 930), and 6) Medicare Opt-out Option (no bill number).
No Bill: Discussed how Stark laws affect the ability of occupational therapy practitioners to provide coordinated care services, particularly as it relates to the management of chronic conditions.
S. 497/HR 930: Lymphedema Treatment Act - Support passage.
No bill: Advocate for role of skilled therapy in changing reimbursement under Medicare Part A and Part B.
HR 6, HR 5722, HR 5774, HR 5776, HR 6110, S 3008 and S 3120: (Various Bills on Opioids) Educate Members of Congress about the role of occupational therapy in the non-pharmacological management of pain, and advocate for any legislation that includes studies or funding for these alternatives, includes occupational therapy.
Discussed and examined the effect of changes to reimbursement for occupational therapy assistants included in the Bi-partisan Budget Act, and possibly requesting a report from the GAO.
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Promote Medicare coverage of physician prescribed compression garments for lymphedema patients. This includes S. 497 and H.R. 930, the Lymphedema Treatment Act.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
Physician self-referra/Stark Law
American Cures Act
H.R. 930/S.497 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
Medicaid Expansion
HR. 1639/S.619 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 302/S.808 Sports Medicine Licensure Clarity Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 1361/S.486 Ensuring Access to Quality CRT
Medicare Telehealth Parity Act HR2550
American Healthcare Act of 2017/CONNECT - H.R. 2556/S1016
H.R. 1628 - American Health Care Action of 2017
Opioid Epidemic/Pain Management
Better Care Reconciliation Act of 2017
H.R.2066 Promoting Integrity in Medicare
H.R. 2063 Opioid Pace Act of 2017
H.R. 5261 Teach Act
H.R. 5197 Alto Act
H.R. 5686, Medicare Clear Health Options in Care for Enrollees Act
H.R. 5773, Preventing Addiction for Susceptible Seniors Act
H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act
H.R. 5718, Perioperative Reduction for Opioids Act
H.R. 5719, Reduce Overprescribing Opioids in Treatment Act
H.R. 5722, Dr. Todd Graham Pain Management Improvement Act
H.R. 6, Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act
S. 3120, the HEAL Act
S. 2680, Opioid Crisis Response Act
Client expense: $251,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment;
H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care;
H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography;
H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue;
S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
Clinical trial policy.
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests.
Client expense: $900,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
S. 977/HR 3820 and HR 6225: Medicare Home Health Flexibility Act - Advocate for passage .
HR 2550: Medicare Telehealth Parity Act of 2017 - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
HR2556: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; S787: A bill to require the Center for Medicare and Medicaid Innovation to test the effect of including telehealth services in Medicare health care delivery reform models; HR3360: Telehealth Enhancement Act; HR3482: Evidence-Based Telehealth Expansion Act; S1016: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; and HR3727: A bill to amend title XVIII of the Social Security Act to include additional telehealth services for purposes of MA organization bids, and for other purposes. - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
No bill# Red Tape Reduction Initiative from Ways and Means Committee: Submitted following priorities for occupational therapy red tape reduction - 1) Initiation of Home Health Therapy Services Under Medicare (S. 977/HR 3820 now HR 6225), 2) Recognition of Occupational Therapy as a Primary Rehab Service (no bill number), 3) Permanently Eliminate Outside Certification Requirement for Occupational Therapists to Fabricate Custom Orthotics and Prosthetic Items (no bill number), 4) Modify or Eliminate Claims-Based Data Collection of Functional Limitation Information for Therapy Services (no bill number), 5) Add Doctor-prescribed Compression Supplies to the Durable Medical Equipment category (S 497/HR 930), and 6) Medicare Opt-out Option (no bill number).
No Bill: Discussed how Stark laws affect the ability of occupational therapy practitioners to provide coordinated care services, particularly as it relates to the management of chronic conditions.
S. 497/HR 930: Lymphedema Treatment Act - Support passage.
No bill: Advocate for role of skilled therapy in changing reimbursement under Medicare Part A.
HR 6, HR 5722, HR 5774, HR 5776, HR 6110, S 3008 and S 3120: (Various Bills on Opioids) Educate Members of Congress about the role of occupational therapy in the non-pharmacological management of pain, and advocate for any legislation that includes studies or funding for these alternatives, includes occupational therapy.
Discussed and examined the effect of changes to reimbursement for occupational therapy assistants included in the Bi-partisan Budget Act, and possibly requesting a report from the GAO.
Client expense: $270,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Promote Medicare coverage of physician prescribed compression garments for lymphedema patients. This includes S. 497 and H.R. 930, the Lymphedema Treatment Act. Monitor Medicare payment extenders as related to HR 1892, the Bipartisan Budget Act of 2018; and HR 1625, the Consolidated Appropriations Act of 2018.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
Physician self-referra/Stark Law
American Cures Act
H.R. 930/S.497 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
Medicaid Expansion
HR. 1639/S.619 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 302/S.808 Sports Medicine Licensure Clarity Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 1361/S.486 Ensuring Access to Quality CRT
Medicare Telehealth Parity Act HR2550
American Healthcare Act of 2017/CONNECT - H.R. 2556/S1016
H.R. 1628 - American Health Care Action of 2017
Opioid Epidemic/Pain Management
Better Care Reconciliation Act of 2017
H.R.2066 Promoting Integrity in Medicare
H.R. 2063 Opioid Pace Act of 2017
H.R. 5261 Teach Act
H.R. 5197 Alto Act
H.R. 5686, Medicare Clear Health Options in Care for Enrollees Act
H.R. 5773, Preventing Addiction for Susceptible Seniors Act
H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act
H.R. 5718, Perioperative Reduction for Opioids Act
H.R. 5719, Reduce Overprescribing Opioids in Treatment Act
H.R. 5722, Dr. Todd Graham Pain Management Improvement Act
H.R. 6, Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act
S. 3120, the HEAL Act
S. 2680, Opioid Crisis Response Act
Client expense: $292,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Client expense: $650,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
S 253/HR 807 - Medicare Access to Rehabilitation Services Act of 2017: Support passage to repeal the Medicare Part B Therapy cap on outpatient rehabilitation, including occupational therapy.
S. 977/HR 3820: Medicare Home Health Flexibility Act - Advocate for passage
HR 2550: Medicare Telehealth Parity Act of 2017 - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
HR2556: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; S787: A bill to require the Center for Medicare and Medicaid Innovation to test the effect of including telehealth services in Medicare health care delivery reform models; HR3360: Telehealth Enhancement Act; HR3482: Evidence-Based Telehealth Expansion Act; S1016: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; and HR3727: A bill to amend title XVIII of the Social Security Act to include additional telehealth services for purposes of MA organization bids, and for other purposes. - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
No bill# Red Tape Reduction Initiative from Ways and Means Committee: Submitted following priorities for occupational therapy red tape reduction - 1) Initiation of Home Health Therapy Services Under Medicare (HR 3820), 2) Recognition of Occupational Therapy as a Primary Rehab Service (no bill number), 3) Permanently Eliminate Outside Certification Requirement for Occupational Therapists to Fabricate Custom Orthotics and Prosthetic Items (no bill number), 4) Modify or Eliminate Claims-Based Data Collection of Functional Limitation Information for Therapy Services (no bill number), 5) Add Doctor-prescribed Compression Supplies to the Durable Medical Equipment category (S 497/HR 930), and 6) Medicare Opt-out Option (no bill number).
S. 497/HR 930: Lymphedema Treatment Act - Support passage.
HR 1892 - Bipartisan Budget Act of 2018: support of Medicare Outpatient Part B Therapy Cap Repeal, opposition to home health payment reform treatment of therapy services, and changes to occupational therapy assistant reimbursement for Medicare Part B.
HR 1625 - Fiscal 2018 Omnibus Appropriations: opposition to proposed changes to payment for group and concurrent therapy in skilled nursing facilities.
No bill: Advocate for role of skilled therapy in changing reimbursement under Medicare Part A.
Client expense: $139,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Promote Medicare coverage of physician prescribed compression garments for lymphedema patients. This includes S. 497 and H.R. 930, the Lymphedema Treatment Act. Monitor Medicare payment extenders as related to HR 1892, the Bipartisan Budget Act of 2018; and HR 1625, the Consolidated Appropriations Act of 2018.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients.
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment;
H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care;
H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography;
H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies;
H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue;
S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Client expense: $1,840,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Client expense: $1,840,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
Physician self-referra/Stark Law
American Cures Act
H.R. 930/S.497 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
Medicaid Expansion
HR. 1639/S.619 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 302/S.808 Sports Medicine Licensure Clarity Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 1361/S.486 Ensuring Access to Quality CRT
Medicare Telehealth Parity Act HR2550
American Healthcare Act of 2017/CONNECT - H.R. 2556/S1016
H.R. 1628 - American Health Care Action of 2017
Opioid Epidemic/Pain Management
Better Care Reconciliation Act of 2017
H.R.2066 Promoting Integrity in Medicare
Client expense: $254,609 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials.
H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients.
H.R.1628, American Health Care Act, advocate for inclusion of patient protections.
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment;
H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care;
H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography;
H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies;
H.R.4122/S.2006, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue;
S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Client expense: $1,840,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Client expense: $1,840,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
S 253/HR 807 - Medicare Access to Rehabilitation Services Act of 2017: Support passage to repeal the Medicare Part B Therapy cap on outpatient rehabilitation, including occupational therapy.
S. 977/HR 3820: Medicare Home Health Flexibility Act - Advocate for passage and introduction in House of Representatives.
HR 2550: Medicare Telehealth Parity Act of 2017 - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
HR2556: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; S787: A bill to require the Center for Medicare and Medicaid Innovation to test the effect of including telehealth services in Medicare health care delivery reform models; HR3360: Telehealth Enhancement Act; HR3482: Evidence-Based Telehealth Expansion Act; S1016: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; and HR3727: A bill to amend title XVIII of the Social Security Act to include additional telehealth services for purposes of MA organization bids, and for other purposes. - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare.
No bill# Red Tape Reduction Initiative from Ways and Means Committee: Submitted following priorities for occupational therapy red tape reduction - 1) Initiation of Home Health Therapy Services Under Medicare (HR 3820), 2) Recognition of Occupational Therapy as a Primary Rehab Service (no bill number), 3) Permanently Eliminate Outside Certification Requirement for Occupational Therapists to Fabricate Custom Orthotics and Prosthetic Items (no bill number), 4) Modify or Eliminate Claims-Based Data Collection of Functional Limitation Information for Therapy Services (no bill number), 5) Add Doctor-prescribed Compression Supplies to the Durable Medical Equipment category (S 497/HR 930), and 6) Medicare Opt-out Option (no bill number).
HR 1628: American Health Care Act - Advocated for mandatory Medicaid benefits such as EPSDT, Medicaid reimbursement in schools, and essential health benefits such as rehab/habilitation and mental health.
Better Care Reconciliation Act, no bill# - Advocated for mandatory Medicaid benefits such as EPSDT, Medicaid reimbursement in schools, and essential health benefits such as rehab/habilitation and mental health.
Graham/Cassidy health care bill,no bill# - Advocated for mandatory Medicaid benefits such as EPSDT, Medicaid reimbursement in schools, and essential health benefits such as rehab/habilitation and mental health.
S. 497/HR 930: Lymphedema Treatment Act - Support passage.
HR 2810 - National Defense Authorization Act of 2018: Advocated for the inclusion of occupational therapy and physical therapist assistants under Tricare coverage and Senate amendments.
HR 1 (PL 115-97), Tax Cuts and Jobs Act: advocated against changes to the tax status of tuition assistance programs included in the House bill; advocated for pay-go to be waived concurrent with the passage of the bill.
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
Physician self-referra/Stark Law
American Cures Act
H.R. 930/S.497 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
Medicaid Expansion
HR. 1639/S.619 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 302/S.808 Sports Medicine Licensure Clarity Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 1361/S.486 Ensuring Access to Quality CRT
Medicare Telehealth Parity Act HR2550
American Healthcare Act of 2017/CONNECT - H.R. 2556/S1016
H.R. 1628 - American Health Care Action of 2017
Opioid Epidemic/Pain Management
Better Care Reconciliation Act of 2017
H.R.2066 Promoting Integrity in Medicare
Client expense: $254,609 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Promote Medicare coverage of physician prescribed compression garments for lymphedema patients. This includes S. 497 and H.R. 930, the Lymphedema Treatment Act. Monitor provisions included in the Medicare Extenders package and S. 870, the Chronic Care Act of 2017.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
Promote Medicare coverage of physician prescribed compression garments for lymphedema patients. This includes S. 497 and H.R. 930, the Lymphedema Treatment Act.
Client expense: Not reported · Firm income: $19,500
Cited source text, amounts, lobbyists, and targets
P.L.111-148, Patient Protection and Affordable Care Act, matters related to the Implementation of breast health education, research and clinical trials.
H.R.1409, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients.
H.R.1628, American Health Care Act, advocate for inclusion of patient protections.
H.R.930/S.497, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment;
H.R.1676/S.693, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care;
H.R.2307, Protecting Access to Lifesaving Screenings Act (PALS Act), advocate for continued access to and coverage for screening mammography;
H.R.2999, Patients Access to Treatment Act, advocate for access to cancer therapies;
S.1045, Save Womens Preventive Care Act, and S.689, Invest in Womens Health Act, protecting access to breast cancer screenings.
S.91, Mobile Mammography Promotion Act, advocate for mobile mammography units to purchase fuel without the federal excise tax.
Client expense: $47,535 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE